Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs Intravenous Tranexamic Acid in Total Knee Arthroplasty
NCT01881568Phase 3Completed
- Sponsor
- Hospital Universitario La Paz
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in hemorrhage (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Blood transfusion rate at 5 days. Started Jan 2013; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT01881568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01881568.